Table 2 Distribution of cases/deaths and sub-hazard ratios from competing risk analysis for each Cambridge Prognostic Group (CPG) category in the PCBaSe cohort (n = 72,337)
CPG | Number of men | Deaths from prostate cancer | Deaths from other causes | Sub-hazard ratio (95% confidence interval) | p value |
|---|---|---|---|---|---|
1 | 25,303 | 482 | 3740 | Reference | NA |
2 | 14,796 | 628 | 2912 | 2.30 (2.04–2.59) | < 0.0001 |
3 | 7354 | 589 | 1532 | 4.70 (4.17–5.30) | < 0.0001 |
4 | 13,506 | 1831 | 4011 | 7.42 (6.71–8.19) | < 0.0001 |
5 | 11,378 | 3632 | 3726 | 20.52 (18.66–22.55) | < 0.0001 |
Total | 72,337 | 7162 | 15,921 | _ | _ |